1. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001;161:1581-6.

2. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 2000;160:2117-28.

3. Burton BT, Foster WR. Health implications of obesity: an NIH Consensus Development Conference. J Am Diet Assoc 1985;85:1117-21.

4. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288:1401-4.

5. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995;141:1117-27.

6. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-8.

7. Krishnan S, Rosenberg L, Djousse L, Cupples LA, Palmer JR. Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring) 2007;15:1860-6.

8. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-8.

9. Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med 1997;242:401-6.

10. Freedman DS, Williamson DF, Croft JB, Ballew C, Byers T. Relation of body fat distribution to ischemic heart disease. The National Health and Nutrition Examination Survey I (NHANES I) Epidemiologic Follow-up Study. Am J Epidemiol 1995;142:53-63.

11.    Adams KF, Schatzkin A, Harris TB, et al. Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. N Engl J Med 2006;355:763-778.

12.    Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity 2007;15:216-24.

13.    Reeder BA, Senthilselvan A, Despres JP, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. Cmaj 1997;157 Suppl 1:S39-45.

14. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.

15.    Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004;27:2444-9.

16. Resnick HE, Jones K, Ruotolo G, et al. Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study. Diabetes Care 2003;26:861-867.

17. Hanson RL, Narayan KM, McCance DR, et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes 1995;44:261-6.

18.    Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. European Heart Journal 2002;23:706-713.

19. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. AJCN 2004;79:379-384.

20.    Zhu SK, Wang ZM, Heshka S, Heo MS, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. AJCN 2002;76:743-749.

21.    Bray GA. Don't throw the baby out with the bath water.AJCN 2004;79:347-349.

22. Bigaard J, Thomsen BL, Tjonneland A. Does waist circumference alone explain obesity-related health risk? AJCN 2004;80:790-791.

23.    Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991;324:1839-44.

24.    French SA, Folsom AR, Jeffery RW, Zheng W, Mink PJ, Baxter JE. Weight variability and incident disease in older women: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 1997;21:217-23.

25. Williamson DF. "Weight cycling" and mortality: how do the epidemiologists explain the role of intentional weight loss? J Am Coll Nutr 1996;15:6-13.

26.    Dyer AR, Stamler J, Greenland S. Associations of weight change and weight variability with cardiovascular and all-cause mortality in the Chicago Western Electric Company Study. American Journal of Epedemiology 2000;152:324-333.

27. Wannamethee SG, Shaper AG, Walker M. Weight change, weight fluctuation, and mortality. Archives Of Internal Medicine 2002;162:2575-2580.

28.    Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-8.

29. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997;66:1044S-1050S.

30.    Waaler HT. Height, weight, and mortality: The Norwegian experience. Acta Medica Scandinavica 1984;679:1-56.

31.    Lew EA. Mortality and weight: Insured lives and the American Cancer Society Studies. Annals of Internal Medicine 1985;103:1024-1029.

32.    Lee I, Manson J, Hennekens C, Paffenbarger RS. Body weight and mortality. JAMA 1993;270:2823-2828.

33. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.

34. Lindsted K, Tonstad S, Kuzma JW. Body mass index and patterns of mortality among Seventh-day Adventist men. Int J Obes 1991;15:397-406.

35.    Singh PN, Lindsted KD, Fraser GE. Body weight and mortality among adults who never smoked. Am J Epidemiol 1999;150:1152-64.

36. Stevens J, Nowicki EM. Body mass index and mortality in Asian populations: Implications for obesity cut-points. Nutrition Reviews 2003;61:104-107.

37.    Misra T. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. International Journal of Obesity 2003;27:1294-1296.

38.    WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report. Series No. 894. Geneva: World Health Organisation, 2000.

39.    Shaper AG, Wannamethee SG, Walker M. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. Bmj 1997;314:1311-7.

40.    Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998;22:39-47.

41. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.

42.    Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555

43. Bjorntorp P. Obesity. Lancet 1997;350:423-6.

44.    Popkin BM. The nutrition transition and obesity in the developing world. J Nutr 2001;131:871S-873S.

45. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med 1999;159:2177-83.

46.    Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999;31:S663-7.

47. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.

48. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000;8:49-61.

49. Higgins M, D'Agostino R, Kannel W, Cobb J, Pinsky J. Benefits and adverse effects of weight loss. Observations from the Framingham Study. Ann Intern Med 1993;119:758-63.

50. Colman E, Katzel LI, Rogus E, Coon P, Muller D, Goldberg AP. Weight loss reduces abdominal fat and improves insulin action in middle- aged and older men with impaired glucose tolerance. Metabolism 1995;44:1502-8.

51.    Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749-53.

52. Osterman J, Lin T, Nankin HR, Brown KA, Hornung CA. Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels. Int J Obes Relat Metab Disord 1992;16:49-58.

53. MacMahon SW, Macdonald GJ, Bernstein L, Andrews G, Blacket RB. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet 1985;1:1233-6.

54.    Grimm RH, Jr., Flack JM, Grandits GA, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996;275:1549-56.

55.    Borkan GA, Sparrow D, Wisniewski C, Vokonas PS. Body weight and coronary disease risk: patterns of risk factor change associated with long-term weight change. The Normative Aging Study. Am J Epidemiol 1986;124:410-9.

56.    Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. International Journal Of Obesity 2004;28:S2-S9.

57. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children - An American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-1453.

58.    Ford ES, Mokdad AH, Ajani UA. Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics 2004;114:1534-1544.

59.    Must A, Hollander SA, Economos CD. Childhood obesity: a growing public health concern. Expert Review of Endocrinology and Metabolism 2005;1:233-55.

60. Hanevold CD, Ho P-L, Talley L, Mitsnefes MM. Obesity and Renal Transplant Outcome: A Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005;115:352-356.

61.    Weiss R, Dziura J, Burgert TS, et al. Obesity and the Metabolic Syndrome in Children and Adolescents.. N Engl J Med 2004;350:2362-2374.

62. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the Diagnosis of Metabolic Syndrome in Adolescents. Circulation 2007;115:2316-2322.

63.    Croft JB, Strogatz DS, Keenan NL, James SA, Malarcher AM, Garrett JM. The independent effects of obesity and body fat distribution on blood pressure in black adults: the Pitt County study. Int J Obes Relat Metab Disord 1993;17:391-7.

64.    Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:605-19.

65. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996;16:1509-15.

66. Cassano PA, Segal MR, Vokonas PS, Weiss ST. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol 1990;1:33-48.

67.    Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998;128:81-8.

68.    Field AE, Byers T, Hunter DJ, et al. Weight cycling, weight gain, and risk of hypertension in women. Am J Epidemiol 1999;150:573-9.

69.    Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.

70. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med 1992;152:131-6.

71. Schotte DE, Stunkard AJ. The effects of weight reduction on blood pressure in 301 obese patients. Arch Intern Med 1990;150:1701-4.

72.    Moore LL, Visioni AJ, Quyeshi MM, Bradlee ML, Ellison RC, Dagostino R. Weight loss in overweight adults and the long-term of hypertension - The Framingham study. Archives Of Internal Medicine 2005;165:1298-1303.

73.    Dyer AR, Elliott P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens 1989;3:299-308.

74. Palmieri V, de Simone G, Arnett DK, et al. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). American Journal Of Cardiology 2001;88:1163-1168.

75.    de Simone G, Devereux RB, Kizer JR, et al. Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. AJCN 2005;81:757-761.

76. Hinderliter A, Sherwood A, Gullette ECD, et al. Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Archives Of Internal Medicine 2002;162:1333-1339.

77.    Jacobs DR, Jr., Burke GL, Liu K, et al. Relationships of low density lipoprotein cholesterol with age and other factors: a cross-sectional analysis of the CARDIA study. Ann Clin Res 1988;20:32-8.

78.    Glueck CJ, Taylor HL, Jacobs D, Morrison JA, Beaglehole R, Williams OD. Plasma high-density lipoprotein cholesterol: association with measurements of body mass. The Lipid Research Clinics Program Prevalence Study. Circulation 1980;62:IV-62-9.

79.    Nanas S, Pan WH, Stamler J, et al. The role of relative weight in the positive association between age and serum cholesterol in men and women. J Chronic Dis 1987;40:887-92.

80.    Ashton WD, Nanchahal K, Wood DA. Body mass index and metabolic risk factors for coronary heart disease in women. Eur Heart J 2001;22:46-55.

81.    Ashley FW, Jr., Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis 1974;27:103-14.

82.    Kannel WB, D'Agostino RB, Cobb JL. Effect of weight on cardiovascular disease. Am J Clin Nutr 1996;63:419S-422S.

83. Jalkanen L. The effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health care. Scand J Soc Med 1991;19:66-71.

84.    Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991;325:461-6.

85. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15- year follow-up of middle-aged men and women in eastern Finland. Circulation 1996;93:1372-9.

86.    Welty FK, Stuart E, O'Meara M, Huddleston J. Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol. American Journal of Cardiology 2002;89:1201.

87.    Gower BA, Weinsier RL, Jordan JM, Hunter GR, Desmond R. Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women.AJCN 2002;76:923-927.

88. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992;70:733-7.

89.    Koba S, Hirano T, Kondo T, et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. American Heart Journal 2002;144:1026-1035.

90. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.

91. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-20.

92.    Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993;153:1093-103.

93. Bjorntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615-22.

94. Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993;9:452-9.

95.    Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.

96.    Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984;33:68-75.

97. Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin- dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83-109.

98.    Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-73.

99. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal Of Clinical Investigation 2004;114:1752-1761.

100. de Jongh RT, Serne EH, Ijzerman RG, de Vries G, Stehouwer CDA. Free fatty acid levels modulate microvascular function - Relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 2004;53:2873-2882.

101. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.

102. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997;46 Suppl 2:S9-13.

103. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980;65:1272-84.

104. Marshall S, Olefsky JM. Characterization of insulin-induced receptor loss and evidence for internalization of the insulin receptor. Diabetes 1981;30:746-53.

105. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity - Reversal with intramyocellular fat depletion. Diabetes 2002;51:144-151.

106. Havel PJ. Update on adipocyte hormones - Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53:S143-S151.

107. McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF, Jr. A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst 1984;72:275-84.

108. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-5.

109. Folsom AR, French SA, Zheng W, Baxter JE, Jeffery RW. Weight variability and mortality: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 1996;20:704-9.

110. Folsom AR, Vitelli LL, Lewis CE, Schreiner PJ, Watson RL, Wagenknecht LE. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts. Int J Obes Relat Metab Disord 1998;22:48-54.

111. Hoag S, Marshall JA, Jones RH, Hamman RF. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: the San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 1995;19:175-80.

112. Folsom AR, Jacobs DR, Jr., Wagenknecht LE, et al. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 1996;144:235-46.

113. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104-9.

114. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992;340:1452-3.

115. Swinburn BA, Nyomba BL, Saad MF, et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991;88:168-73.

116. Johnson MS, Figueroa-Colon R, Huang TTK, Dwyer JH, Goran MI. Longitudinal changes in body fat in African American and Caucasian children: Influence of fasting insulin and insulin sensitivity. Journal Of Clinical Endocrinology And Metabolism 2001;86:3182-3187.

117. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 1996;20:213-9.

118. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Waist circumference vs body mass index for prediction of disease risk in postmenopausal women. Int J Obes Relat Metab Disord 2001;25:1183-8.

119. Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 2005;54:770-777.

120. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882-9.

121. Fitzgerald AP, Jarrett RJ. Body weight and coronary heart disease mortality: an analysis in relation to age and smoking habit. 15 years follow-up data from the Whitehall Study. Int J Obes Relat Metab Disord 1992;16:119-23.

122. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995;273:461-5.

123. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA 1987;257:353-8.

124. Reed D, Yano K. Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Comparisons of cohort and arteriography series analyses. Am J Epidemiol 1991;134:111-22.

125. Nanchahal K, Morris JN, Sullivan LM, Wilson PWF. Coronary heart disease risk in men and the epidemic of overweight and obesity. International Journal Of Obesity 2005;29:317-323.

126. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.

127. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998;97:2099-100.

128. Dagenais GR, Yi Q, Mann JFE, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. American heart journal 2005;149:54-60.

129. Rea TD, Heckbert SR, Kaplan RC, et al. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. American Journal Of Cardiology 2001;88:467-472.

130. Al Suwaidi J, Higano ST, Holmes DR, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. Journal Of The American College Of Cardiology 2001;37:1523-1528.

131. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index - A risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003;108:2206-2211.

132. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.

133. Jarrett RJ, Shipley MJ, Rose G. Weight and mortality in the Whitehall Study. Br Med J (Clin Res Ed) 1982;285:535-7.

134. Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L. Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 1988;259:1520-4.

135. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA 1993;269:483-7.

136. Borkan GA, Hults DE, Gerzof SG, Robbins AH. Comparison of body composition in middle-aged and elderly males using computed tomography. Am J Phys Anthropol 1985;66:289-95.

137. Pamuk ER, Williamson DF, Serdula MK, Madans J, Byers TE. Weight loss and subsequent death in a cohort of U.S. adults. Ann Intern Med 1993;119:744-8.

138. Megnien JL, Denarie N, Cocaul M, Simon A, Levenson J. Predictive value of waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord 1999;23:90-7.

139. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. International Journal Of Obesity 2004;28:1018-1025.

140. Kortelainen ML, Sarkioja T. Visceral fat and coronary pathology in male adolescents. International Journal Of Obesity 2001;25:228-232.

141. Zhang X, Shu XO, Gao YT, et al. Anthropometric predictors of coronary heart disease in Chinese women. International Journal Of Obesity 2004;28:734-740.

142. Lofgren I, Herron K, Zern T, et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. Journal Of Nutrition 2004;134:1071-1076.

143. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. International Journal Of Obesity 2001;25:1047-1056.

144. Sonmez K, Akcakoyun M, Akcay A, et al. Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio). International Journal Of Obesity 2003;27:341-346.

145. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA project. Journal Of Clinical Epidemiology 1999;52:1213-1224.

146. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat.AJCN 2002;75:683-688.

147. Ardern CL, Katzmarzyk PT, Janssen I, Ross R. Discrimination of health risk by combined body mass index and waist circumference. Obesity Research 2003;11:135-142.

148. Hamm P, Shekelle RB, Stamler J. Large fluctuations in body weight during young adulthood and twenty- five-year risk of coronary death in men. Am J Epidemiol 1989;129:312-8.

149. Cho EY, Manson JE, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 2002;25:1142-1148.

150. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJP. Early growth and coronary heart disease in later life: longitudinal study. British Medical Journal 2001;322:949-953.

151. Syddall HE, Sayer AA, Simmonds SJ, et al. Birth weight, infant weight gain, and cause-specific mortality - The Hertfordshire cohort study. American Journal Of Epidemiology 2005;161:1074-1080.

152. Khaw KT, Barrett-Connor E, Suarez L, Criqui MH. Predictors of stroke-associated mortality in the elderly. Stroke 1984;15:244-8.

153. Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke 1990;21:701-6.

154. Shinton R, Shipley M, Rose G. Overweight and stroke in the Whitehall study. J Epidemiol Community Health 1991;45:138-42.

155. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996;144:1143-50.

156. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997;277:1539-45.

157. Abbott RD, Behrens GR, Sharp DS, et al. Body mass index and thromboembolic stroke in nonsmoking men in older middle age. The Honolulu Heart Program. Stroke 1994;25:2370-6.

158. Hart CL, Hole DJ, Smith GD. Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke 2000;31:1893-6.

159. DiPietro L, Ostfeld AM, Rosner GL. Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study. Am J Public Health 1994;84:14-9.

160. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Archives Of Internal Medicine 2002;162:2557-2562.

161. Song YM, Sung J, Smith GD, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke - A prospective study in Korean men. Stroke 2004;35:831-836.

162. Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index in mid-life is associated with a first stroke in men - A prospective population study over 28 years. Stroke 2004;35:2764-2769.

163. Dey DK, Rothenberg E, Sundh V, Bosaeus I, Steen B. Waist circumference, body mass index, and risk for stroke in older people - A 15-year longitudinal population study of 70-year-olds. Journal Of The American Geriatrics Society 2002;50:1510-1518.

164. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984;289:1257-61.

165. Suk SH, Sacco RL, Boden-Albala B, et al. Abdominal obesity and risk of ischemic stroke - The Northern Manhattan Stroke Study. Stroke 2003;34:1586-1592.

166. Federation ID. 2005. Diabetes Atlas, third edition © International Diabetes Federation, 2006 (http://www.eatlas.idf.org/media)

167. WHO. Obesity-preventing and managing the global epidemic. Geneva: World Health Org, 1997.

168. Gregg EW, Cheng YLJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA-Journal Of The American Medical Association 2005;293:1868-1874.

169. Dowse GK, Zimmet PZ, Gareeboo H, et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991;14:271-82.

170. Morris RD, Rimm DL, Hartz AJ, Kalkhoff RK, Rimm AA. Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol 1989;130:112-21.

171. Defay R, Delcourt C, Ranvier M, Lacroux A, Papoz L. Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study. Int J Obes Relat Metab Disord 2001;25:512-8.

172. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.

173. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.

174. Brancati FL, Wang NY, Mead LA, Liang KY, Klag MJ. Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med 1999;159:957-63.

175. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.

176. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214-22.

177. Wang YF, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men.AJCN 2005;81:555-563.

178. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997;145:614-9.

179. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998;351:853-6.

180. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. Obes Res 1997;5:16-23.

181. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999;22:1266-72.

182. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations - Distinct metabolic effects of two fat compartments. Diabetes 2002;51:1005-1015.

183. Holbrook TL, Barrett-Connor E, Wingard DL. The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obes 1989;13:723-9.

184. Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition'.AJCN 2004;80:257-263.

185. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care 2005;28:888-894.

186. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-23.

187. Long SD, O'Brien K, MacDonald KG, Jr., et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 1994;17:372-5.

188. Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 1998;21:350-9.

189. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34:891-8.

190. Smith GD, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Annals Of Internal Medicine 2005;142:313-322.

191. Polednak AP. Trends in incidence rates for obesity-associated cancers in the US. Cancer Detection And Prevention 2003;27:415-421.

192. World Cancer Research Fund/American Institute for Cancer Research.  Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997.

193. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216:28-43.

194. Tornberg SA, Carstensen JM. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer 1994;69:358-61.

195. Sonnenschein E, Toniolo P, Terry MB, et al. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol 1999;28:1026-31.

196. den Tonkelaar I, Seidell JC, Collette HJ, de Waard F. Obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women participating in the Diagnostic Investigation of Mammary Cancer Project. Cancer 1992;69:2663-7.

197. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.

198. Tretli S. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 1989;44:23-30.

199. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol 1996;143:985-95.

200. Willett WC, Browne ML, Bain C, et al. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 1985;122:731-40.

201. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989;262:2853-8.

202. De Stavola BL, Wang DY, Allen DS, et al. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom). Cancer Causes Control 1993;4:331-40.

203. Vatten LJ, Kvinnsland S. Prospective study of height, body mass index and risk of breast cancer. Acta Oncol 1992;31:195-200.

204. Vatten LJ, Kvinnsland S. Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer 1990;45:440-4.

205. Kuller LH, Meilahn EN, Cauley JA, Gutai JP, Matthews KA. Epidemiologic studies of menopause: changes in risk factors and disease. Exp Gerontol 1994;29:495-509.

206. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996;88:756-8.

207. Tornberg SA, Holm LE, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum beta- lipoprotein, height, weight, and blood pressure. Acta Oncol 1988;27:31-7.

208. Ziegler RG, Hoover RN, Nomura AM, et al. Relative weight, weight change, height, and breast cancer risk in Asian- American women. J Natl Cancer Inst 1996;88:650-60.

209. Huang Z, Willett WC, Colditz GA, et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 1999;150:1316-24.

210. Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992;326:1323-9.

211. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.

212. Bruning PF, Bonfrer JM, Hart AA, et al. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992;51:14-9.

213. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63:437S-41S.

214. Barnes-Josiah D, Potter JD, Sellers TA, Himes JH. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States). Cancer Causes Control 1995;6:112-8.

215. Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res 1989;49:6828-31.

216. Anderson KE, Anderson E, Mink PJ, et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2001;10:611-6.

217. Tretli S, Magnus K. Height and weight in relation to uterine corpus cancer morbidity and mortality. A follow-up study of 570,000 women in Norway. Int J Cancer 1990;46:165-72.

218. Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer 1992;50:567-71.

219. Shu XO, Brinton LA, Zheng W, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res 1992;52:3865-70.

220. Swanson CA, Potischman N, Wilbanks GD, et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993;2:321-7.

221. Olson SH, Trevisan M, Marshall JR, et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 1995;23:141-9.

222. Goodman MT, Hankin JH, Wilkens LR, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077-85.

223. Le Marchand L, Wilkens LR, Mi MP. Early-age body size, adult weight gain and endometrial cancer risk. Int J Cancer 1991;48:807-11.

224. Austin H, Austin JM, Jr., Partridge EE, Hatch KD, Shingleton HM. Endometrial cancer, obesity, and body fat distribution. Cancer Res 1991;51:568-72.

225. Xu WH, Matthews CE, Xiang YB, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. American Journal Of Epidemiology 2005;161:939-947.

226. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. European journal of cancer (Oxford, England : 1990) 2001;37:4-66.

227. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327-34.

228. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 1994;57:313-7.

229. Kreger BE, Anderson KM, Schatzkin A, Splansky GL. Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer 1992;70:1038-43.

230. Lee IM, Paffenbarger RS, Jr. Quetelet's index and risk of colon cancer in college alumni. J Natl Cancer Inst 1992;84:1326-31.

231. Murphy TK, Calle EE, Rodriguez C, Khan HS, Thun MJ. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000;152:847-54.

232. Chute CG, Willett WC, Colditz GA, et al. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control 1991;2:117-24.

233. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997;89:948-55.

234. Bostick RM, Potter JD, Kushi LH, et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994;5:38-52.

235. Terry MB, Neugut AI, Bostick RM, et al. Risk Factors for Advanced Colorectal Adenomas: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622-629.

236. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes & Control 2003;14:75-84.

237. Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. International Journal Of Obesity 2004;28:559-567.

238. Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 1986;77:351-6.

239. McLaughlin JK, Gao YT, Gao RN, et al. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer 1992;52:562-5.

240. Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993;4:101-10.

241. Maclure M, Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1990;1:430-40.

242. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer 1994;56:66-71.

243. Wynder EL, Mabuchi K, Whitmore WF, Jr. Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 1974;53:1619-34.

244. Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer--a quantitative review. Br J Cancer 2001;85:984-90.

245. Prineas RJ, Folsom AR, Zhang ZM, Sellers TA, Potter J. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology 1997;8:31-6.

246. Strom BL, Soloway RD, Rios-Dalenz JL, et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995;76:1747-56.

247. Chow WH, Gridley G, Fraumeni JF, Jr., Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000;343:1305-11.

248. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-76.

249. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997;89:1132-8.

250. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244-50.

251. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;3:344-50.

252. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89:385-9.

253. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604.

254. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5:276-82.

255. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997;6:557-63.

256. Amling CL, Kane CJ, Riffenburgh RH, et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001;58:723-728.

257. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group. Journal Of Clinical Oncology 2004;22:446-453.

258. Baillargeon J, Pollock BH, Kristal AR, et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005;103:1092-1095.

259. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level <= 4.0 ng per milliliter. New England Journal Of Medicine 2004;350:2239-2246.

260. Kane CJ, Bassett WW, Sadetsky N, et al. Obesity and prostate cancer clinical risk factors at presentation: Data from CaPSURE. Journal Of Urology 2005;173:732-736.

261. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Annals of Internal Medicine 1993;119:1029-1035.

262. Reuben A, Quershi Y, Murphy GM, Dowling RH. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. European Journal of Clinical Investigation 1986;16:133-42.

263. Everhart JE. Gallstones and ethnicity in the Americas. Journal of the Association for Academic Minority Physicians 2001;12:137-43.

264. Grodstein F, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ. A prospective study of symptomatic gallstones in women: Relation with oral contraceptives and other risk factors. Obstetrics & Gynecology 1994;84:207-214.

265. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men.AJCN 2004;80:38-44.

266. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC, et al. Strong Association between Gallstones and Cardiovascular Disease

doi:10.1111/j.1572-0241.2005.41214.x. The American Journal of Gastroenterology 2005;100:827-830.

267. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001;25:669-75.

268. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-11.

269. Strohl KP, Strobel RJ, Parisi A. Obesity and pulmonary function. In: Bray GA, Bouchard C, James WP, eds. Handbook of Obesity. New York: Marchel Dekker, 1997:725-739.

270. Chen Y, Dales R, Krewski D, Breithaupt K. Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995. Am J Epidemiol 1999;150:255-62.

271. Camargo CA, Jr., Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult- onset asthma in women. Arch Intern Med 1999;159:2582-8.

272. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005;90:4510-5.

273. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.

274. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990;141:1228-31.

275. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-5.

276. Rajala R, Partinen M, Sane T, Pelkonen R, Huikuri K, Seppalainen AM. Obstructive sleep apnoea syndrome in morbidly obese patients. J Intern Med 1991;230:125-9.

277. Schwartz AR, Gold AR, Schubert N, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991;144:494-8.

278. Grunstein RR, Stenlof K, Hedner J, Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995;19:410-8.

279. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-4.

280. Koskenvuo M, Kaprio J, Langinvainio H, Romo M, Pulkkinen P. Changes in incidence and prognosis of ischaemic heart disease in Finland: a record linkage study of data on death certificates and hospital records for 1972 and 1981. Br Med J (Clin Res Ed) 1985;290:1773-5.

281. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. American Journal Of Respiratory And Critical Care Medicine 2002;165:677-682.

282. Bailey WC, Richards JM, Jr., Manzella BA, Brooks CM, Windsor RA, Soong SJ. Characteristics and correlates of asthma in a university clinic population. Chest 1990;98:821-8.

283. Gold DR, Rotnitzky A, Damokosh AI, et al. Race and gender differences in respiratory illness prevalence and their relationship to environmental exposures in children 7 to 14 years of age. Am Rev Respir Dis 1993;148:10-8.

284. Ford ES, Mannino DM. Time trends in obesity among adults with asthma in the United States: Findings from three national surveys. Journal Of Asthma 2005;42:91-95.

285. Young SYN, Gunzenhauser JD, Malone KE, McTiernan A. Body mass index and asthma in the military population of the northwestern United States. Archives Of Internal Medicine 2001;161:1605-1611.

286. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004;125:2046-2052.

287. Hartz AJ, Fischer ME, Bril G, et al. The association of obesity with joint pain and osteoarthritis in the HANES data. Journal of Chronic Diseases 1986;39:311-319.

288. Felson DT. The epidemiology of knee osteoarthritis: results from the framingham osteoarthritis study. Seminars in Arthritis and Rheumatism 1990;20:42-50.

289. Manninen P, Riihimaki H, Heliovaara M, Makela P. Overweight, gender and knee osteoarthritis. International Journal of Obesity & Related Metabolic Disorders 1996;20:595-7.

290. Davis MA, Ettinger WH, Neuhaus JM. Obesity and osteoarthritis of the knee: evidence from the National Health and Nutrition Examination Survey (NHANES I). Seminars in Arthritis & Rheumatism 1990;20:34-41.

291. Doherty M. Risk factors for progression of knee osteoarthritis. Lancet 2001;358:775-776.

292. Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C. Knee osteoarthritis and obesity. International Journal of Obesity & Related Metabolic Disorders 2001;25:622-7.

293. Anonymous. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15.

294. Messier SP, Loeser RF, Miller GD, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis - The arthritis, diet, and activity promotion trial. Arthritis And Rheumatism 2004;50:1501-1510.

295. Lievense AM, Bierma-Zeinstra SMA, Verhagen AP, van Baar ME, Verhaar JAN, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology 2002;41:1155-1162.

296. Gelber AC. Obesity and hip osteoarthritis: The weight of the evidence is increasing. American Journal Of Medicine 2003;114:158-159.

297. Lievense AM, Reijman M, Pols HAP, Bierma-Zeinstra SMA. Obesity and hip osteoarthritis. American Journal Of Medicine 2003;115:329-329.

298. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 1992;99:546-52.

299. Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index. An independent predictor of cataract. Arch Ophthalmol 1995;113:1131-7.

300. Hiller R, Podgor MJ, Sperduto RD, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998;105:1244-50.

301. Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE, Hennekens CH. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr 2000;72:1495-502.

302. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. India-US Case- Control Study Group. Arch Ophthalmol 1989;107:670-6.

303. Leske MC, Chylack LT, Jr., Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-51.

304. Jacques PF, Moeller SM, Hankinson SE, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities.AJCN 2003;78:400-405.

305. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. A prospective study of the relationship between body mass index and cataract extraction among US women and men. International Journal Of Obesity 2002;26:1588-1595.

306. Rhoads GG, Kagan A. The relation of coronary disease, storke, and mortality to weight in youth and in middle age. The Lancet 1983;March:492-495.

307. Hoffmans MDAF, Kromhout D, de Lezenne Coulander C. The impact of body mass index of 78,612 18-yr.old Dutch men on 32 year mortality from all causes. Journal of Clinical Epidemiology 1988;41:749-756.

308. Sorensen TIA, Sonne-Holm S. Mortality in extremely overweight young men. Journal of Chronic Diseases 1977;30:359-367.

309. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. JAMA 1987;257:353-358.

310. US Department of Agriculture.  US Department of Health and Human Services. Nutrition and your health: dietary guidelines for Americans.  US Government Printing Office; Washington, DC, 1995.

311. Williamson DF, Kahn HS, Remington PL, Anda RF. The 10-year incidence of overweight and major weight gain in US adults. Archives of Internal Medicine 1990;150:665-672.

312. Stevens J. Impact of age on associations between weight and mortality. Nutrition Reviews 2000;58:129-37.

313. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:1-7.

314. Flegal KM, Williamson DF, Pamuk ER, Rosenberg HM. Estimating deaths attributable to obesity in the United States. American Journal Of Public Health 2004;94:1486-1489.

315. Hu FB, Willett WC, Stampfer M, Spiegelman D, Colditz GA. Calculating deaths attributable to obesity. American Journal Of Public Health 2005;95:932-932.